Introduction
============

In 1994 the EAFP, under the direction of P. Bourlioux, University Paris XI, France, brought out a document surveying the state of pharmacy education in the EU of that time (document available at: <http://enzu.pharmine.org/media/filebook/files/Bourlioux_full_report.pdf>). In 2006 the EAFP decided to repeat this study and enlarge it to European pharmacy practice. To this end the PHARMINE consortium was created amongst EAFP members.

The PHARMINE consortium, created in 2008, consists of 50 universities from EU member states or other European countries that are members of the European Association of Faculties of Pharmacy (EAFP). EU partner associations representing community (PGEU), hospital (EAHP) and industrial pharmacy (EIPG), together with the European Pharmacy Students' Association (EPSA) are also part of the consortium.

The consortium surveyed pharmacies and pharmacists in different settings: community, hospital, industry and other sectors. The consortium also looked at how EU higher education institutions, courses and traineeship were organised. An empirical -- based on statistical analysis of data - rather than an intuitive approach was used to avoid anecdotal conceptualisation. The fundamental question asked was: is pharmacy education adapted to needs?

This is the 2011 report for the EU. Further reports will be edited in the future as the data for EU member states are completed, data from other European countries are obtained, situations in individual countries change, etc.

Methods
=======

The survey ran between the spring of 2009 and the summer of 2011. An electronic version was sent out to at least 2 faculties per country (excepting countries with only 1 faculty e.g. Estonia). We planned for a balanced design and obtained data from at least 1 faculty per country; in some cases we did not obtain data from 2 faculties.

In some cases, data were expressed per population (in millions, M). The population of the different member states used in the analysis was that as of 1st January 2009 given in the European Commission Eurostat demography report for 2011 <http://epp.eurostat.ec.europa.eu/portal/page/portal/population/documents/Tab/report.pdf>.

Statistical analysis
--------------------

Data (n=25) were obtained from the 27 EU member states excepting Cyprus and Luxembourg that do not have full pharmacy degree courses. When data were obtained from 2 faculties in the same country, the data from the larger faculty was used.

Results are expressed as medians with 10 and 90% percentiles. The Kolmogorov--Smirnov (KS) test for deviations of distribution from normality was significant with positive skewness -- a bunching of values below the mean with a long tail above: one-tailed percentage points for skewness =0.711 (n=25 and α=0.05). Skewness was due to the uneven distribution of population in the EU. Twenty % of the population of the EU live in 17 smaller countries: Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, Finland, Greece, Hungary, Ireland, Latvia, Lithuania, Malta, Portugal, Slovakia, Slovenia and Sweden, and 80% in 8 larger countries: France, Germany, Italy, The Netherlands, Poland, Romania, Spain and United Kingdom. Kurtosis (an excess of values near the mean and far from it with a corresponding depletion of the flanks of the normal distribution curve) was rarely significant (percentage point for distribution =3.99, for n=50 and α=0.05).

In order to compare data for an individual country with an EU "average", several possibilities were envisaged. Comparing the data for a given country with the EU mean was judged invalid as distributions were often not normal (see previous paragraph). Comparisons with medians were also invalid as medians were equal to zero in some cases. It was decided to use an EU linear regression estimation. This was calculated as follows: estimations of numbers of pharmacies, etc. as the dependent variable were calculated from the linear regression equation with population as the independent variable with the condition that when X=0, Y=0. The reported number for the country was then expressed as a ratio of the estimated number. Taking community pharmacies in France as an example: with X=population and Y=community pharmacies, forcing the linear regression through Y=0 when X=0, gives a slope of 298 ±18 (test of slope≠0: P\<0.0001; n=25 countries). Thus the EU linear regression estimation of the number of pharmacies in France =64.7 million x 298 =19,280. The reported number of pharmacies is 23,133, thus giving a ratio compared to the estimate of 23,133/19,280 =1.20 (see table 6). France therefore has 1.2 times more pharmacies than to be expected from the EU linear regression estimation or EU "average".

Statview® (http://statview.com/), GraphPad® (www.graphpad.com) and nQuery® (www.statistical-solutions-software.com) programs were used.

Complete data for each country can be obtained on the PHARMINE website at: <http://www.pharmine.org/losse_paginas/Country_Profiles/> . These profiles were written by the various members of the PHARMINE consortium (see below). Data were checked by JA with that available on the internet, where possible.

Documentation of the Counselling Process and Data Analysis
----------------------------------------------------------

Durinexxxxxxxxxxxxxws

Results
=======

EU population and number of pharmacists
---------------------------------------

The population of the 25 EU member states under consideration is 501 million. A total of 419,353 pharmacists work in these 25 countries, with 81% in community pharmacy, 5% in hospital pharmacy, 7% in industrial pharmacy and 10% in other occupations ([tables 1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}). Tasks carried out in each of the 4 sectors, as reported, are given in [table 3](#T3){ref-type="table"}. The median values for population, number of pharmacists and population per pharmacist are 10 million, 6,278 and 1,593 ([tables 1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}, [4](#T4){ref-type="table"} and [5](#T5){ref-type="table"}).

###### 

EU pharmacists: reported data (NA: data not available).

                           Population (millions)   Community pharmacists   \% total   Hospital pharmacists   \% total   Industrial pharmacists   \% total   Other occupations   \% total   Total number of pharmacists
  ------------------------ ----------------------- ----------------------- ---------- ---------------------- ---------- ------------------------ ---------- ------------------- ---------- -----------------------------
  Austria                  8.4                     5,160                   94.6       292                    5.4        NA                       \-         NA                  \-         5,452
  Belgium                  10.8                    12,000                  90.2       500                    3.8        800                      6          NA                  \-         13,300
  Bulgaria                 7.6                     6,000                   84.3       114                    1.6        1000                     14.1       NA                  \-         7,114
  Czech Republic           10.5                    6,000                   95.6       220                    3.5        15                       0.2        43                  0.7        6,278
  Denmark                  5.5                     952                     25.9       270                    7.4        1900                     51.7       550                 15         3,672
  Estonia                  1.3                     1,165                   75.9       100                    6.5        20                       1.3        250                 16.3       1,535
  Finland                  5.4                     1,406                   45.8       545                    17.7       800                      26.1       320                 10.4       3,071
  France                   64.7                    55,455                  72.9       5,574                  7.3        4752                     6.2        10,309              13.5       76,090
  Germany                  81.8                    57,353                  81.1       1,890                  2.7        5500                     7.8        6,019               8.5        70,762
  Greece                   11.3                    11,342                  87         302                    2.3        144                      1.1        1,250               9.6        13,038
  Hungary                  10.0                    4,900                   62.4       350                    4.5        1200                     15.3       1,400               17.8       7,850
  Ireland                  4.5                     3,400                   84.1       474                    11.7       85                       2.1        83                  2.1        4,042
  Italy                    60.4                    40,346                  85.1       2745                   5.8        4300                     9.1        NA                  \-         47,391
  Latvia                   2.2                     1,624                   80.5       94                     4.7        300                      14.9       NA                  \-         2,018
  Lithuania                3.3                     2,947                   93.5       NA                     \-         85                       2.7        120                 3.8        3,152
  Malta                    0.4                     281                     45         120                    19.2       71                       11.4       152                 24.4       624
  Netherlands              16.6                    3,100                   62         400                    8          NA                       \-         1,500               30         5,000
  Poland                   38.1                    21,534                  95.1       1,100                  4.9        NA                       \-         NA                  \-         22,634
  Portugal                 10.6                    6,108                   56.4       738                    6.8        674                      6.2        3,313               30.6       10,833
  Rumania                  21.5                    13,500                  93.8       692                    4.8        100                      0.7        100                 0.7        14,392
  Slovakia                 5.4                     2,900                   89         159                    4.9        200                      6.1        NA                  \-         3,259
  Slovenia                 2.0                     906                     56.5       78                     4.9        470                      29.3       150                 9.4        1,604
  Spain                    47.2                    48,000                  77.9       1,612                  2.6        11996                    19.5       NA                  \-         61,608
  Sweden                   9.3                     1,400                   43.8       200                    6.3        1200                     37.5       400                 12.5       3,200
  United Kingdom           62.0                    21,712                  69.1       6,213                  19.8       1137                     3.6        2,372               7.5        31,434
  NA: data not available                                                                                                                                                                   

###### 

EU pharmacists: statistical analysis.

                                        Community pharmacists   \% total   Hospital pharmacists   \% total   Industrial pharmacists   \% total   Other occupations   \% total   Total number of pharmacists
  ------------------------------------- ----------------------- ---------- ---------------------- ---------- ------------------------ ---------- ------------------- ---------- -----------------------------
  Number of values                      25                      25         24                     24         22                       22         17                  17         25
  Median                                5,160                   81         375                    5.2        737                      7          400                 10         6,278
  10% Percentile                        934                     45         97                     2.5        35                       0.82       75                  0.7        1576
  90% Percentile                        50,982                  95         4,159                  18         5,276                    35         6,877               30         65,270
  Mean                                  13,180                  74         1,033                  7          1,670                    12         1,667               13         16,774
  Standard deviation                    17,739                  19         1,635                  5.1        2801                     13         2,720               9.2        22,603
  Standard error                        3,548                   3.9        334                    1          597                      2.8        660                 2.2        4521
  KS normality test                                                                                                                                                              
  KS distance                           0.29                    0.15       0.32                   0.26       0.34                     0.19       0.29                0.12       0.3
  P value                               \<0.0001                \>0.10     \<0.0001               0.0002     \<0.0001                 0.04       0.0005              \>0.10     \<0.0001
  Passed normality test (alpha=0.05)?   No                      Yes        No                     No         No                       No         No                  Yes        No
  Skewness                              1.7                     -0.87      2.5                    1.7        2.8                      1.6        2.5                 0.71       1.8
  Kurtosis                              1.6                     -0.07      5.7                    2.1        8.7                      2.6        6.3                 -0.09      2
  Sum                                   329,491                 1,848      24,782                 167        36,749                   273        28,331              213        419,353

###### 

Activities and occupations of pharmacists in the EU.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Community                                                                                                                  Hospital                                                                        Industrial                                    Other
  -------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------- --------------------------------------------- ------------------------------------------------
  • preparation of medicines\                                                                                                • purchasing, stocking, distribution of drugs\                                  • research and development of drugs\          • clinical biology / chemistry\
  • dispensing of medicines\                                                                                                 • management of drug budget\                                                    • synthesis and production\                   • academia\
  • substitution by generic drugs\                                                                                           • preparation of drugs for specific pathologies. e.g. anticancer drugs\         • preclinical and clinical drug evaluation\   • wholesale and distribution of medicines\
  • customer counselling on\                                                                                                 • specialised medical devices and material\                                     • marketing authorisation\                    • armed forces, fire service, police\
  • medicinal prescriptions\                                                                                                 • sterile preparations\                                                         • quality assurance\                          • communication, marketing\
  • use of self-medication medicines\                                                                                        • radio-chemicals\                                                              • marketing\                                  • state and local governments\
  • dietetic products for adults and babies\                                                                                 • quality assurance\                                                            • management of complaints, recalls\          • insurance companies\
  • programs on addictive drug substitution\                                                                                 • Interaction and communication with others: doctors, nurses, hospital board\   • food industry\                              • IT database and technology\
  • nicotine replacement drugs and strategies\                                                                               • prescription of drugs under certain circumstances\                            • cosmetology\                                • family planning clinics\
  • blood pressure, glycaemia. cholesterol monitoring/screening\                                                             • participation in clinical trials\                                             • biotechnology                               • labile blood products, transfusion services\
  • reporting of adverse drug reactions                                                                                      • teaching of hospital staff, pharmacy students\                                                                              • humanitarian aid
                                                                                                                             • personalised medicine service                                                                                               

  Table based on replies from 25 member states. Not all activities and / or occupations may be present in a given country.                                                                                                                                 
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Community pharmacists. Pharmacies and assistants: reported data.

                           Population (millions)   Community pharmacists   Population /pharmacist   Community pharmacies   Population /pharmacy   Pharmacists /pharmacy   Assistants   Assistants /pharmacy
  ------------------------ ----------------------- ----------------------- ------------------------ ---------------------- ---------------------- ----------------------- ------------ ----------------------
  Austria                  8.4                     5,160                   1,628                    1,270                  6,614                  4.06                    5,278        4.16
  Belgium                  10.8                    12,000                  900                      5,729                  1,885                  2.09                    6,500        1.13
  Bulgaria                 7.6                     6,000                   1,267                    4,500                  1,689                  1.33                    NA           NA
  Czech Republic           10.5                    6,000                   1,750                    2,420                  4,339                  2.48                    4,600        1.9
  Denmark                  5.5                     952                     5,777                    318                    17,296                 2.99                    3,200        10.06
  Estonia                  1.3                     1,165                   1,116                    496                    2,621                  2.35                    748          1.51
  Finland                  5.4                     1,406                   3,841                    805                    6,708                  1.75                    3,839        4.77
  France                   64.7                    55,455                  1,167                    23,133                 2,797                  2.4                     35,000       1.51
  Germany                  81.8                    57,353                  1,426                    21,390                 3,824                  2.68                    12,192       0.57
  Greece                   11.3                    11,342                  996                      10,890                 1,038                  1.04                    4,032        0.37
  Hungary                  10.0                    4,900                   2,041                    2,380                  4,202                  2.06                    5,400        2.27
  Ireland                  4.5                     3,400                   1,324                    1,616                  2,785                  2.1                     539          0.33
  Italy                    60.4                    40,346                  1,497                    17,617                 3,429                  2.29                    NA           NA
  Latvia                   2.2                     1,624                   1,355                    810                    2,716                  2.00                    1,481        1.83
  Lithuania                3.3                     2,947                   1,120                    1,320                  2,500                  2.23                    1,890        1.43
  Malta                    0.4                     281                     1,423                    204                    1,961                  1.38                    184          0.9
  Netherlands              16.6                    3,100                   5,355                    2,000                  8,300                  1.55                    17,000       8.5
  Poland                   38.1                    21,534                  1,769                    10,628                 3,585                  2.03                    20,052       1.89
  Portugal                 10.6                    6,108                   1,735                    2,667                  3,975                  2.29                    4,596        1.72
  Rumania                  21.5                    13,500                  1,593                    5,796                  3,709                  2.33                    120,000      20.7
  Slovakia                 5.4                     2,900                   1,862                    1,848                  2,922                  1.57                    2,080        1.13
  Slovenia                 2.0                     906                     2,208                    296                    6,757                  3.06                    456          1.54
  Spain                    47.2                    48,000                  983                      21,057                 2,242                  2.28                    NA           NA
  Sweden                   9.3                     1,400                   6,643                    1,200                  7,750                  1.17                    6,800        5.67
  United Kingdom           62.0                    21,712                  2,856                    13,693                 4,528                  1.59                    14,838       1.08
  NA: data not available                                                                                                                                                               

###### 

Community pharmacists. pharmacies and assistants: statistical analysis.

                                        Community pharmacists   Population /pharmacist   Community pharmacies   Population /pharmacy   Pharmacists /pharmacy   Assistants   Assistants /pharmacy
  ------------------------------------- ----------------------- ------------------------ ---------------------- ---------------------- ----------------------- ------------ ----------------------
  Number of values                      25                      25                       25                     25                     25                      22           22
  Median                                5,160                   1,593                    2,380                  3,585                  2.10                    4,598        1.63
  10% Percentile                        933.6                   991.1                    309.2                  1,807                  1.266                   480.9        0.43
  90% Percentile                        50,982                  5,524                    21,190                 7,970                  3.018                   30516        9.592
  Mean                                  13,180                  2,145                    6,163                  4,407                  2.124                   12305        3.408
  Standard deviation                    17,739                  1,569                    7,466                  3,315                  0.6593                  25,443       4.636
  Standard error                        3548                    313.7                    1493                   663                    0.1319                  5424         0.9885
  KS normality test                                                                                                                                                          
  KS distance                           0.2949                  0.2916                   0.2802                 0.2454                 0.1377                  0.3169       0.3242
  P value                               \<0.0001                \<0.0001                 \<0.0001               0.0004                 \>0.10                  \<0.0001     \<0.0001
  Passed normality test (alpha=0.05)?   No                      No                       No                     No                     Yes                     No           No
  Skewness                              1.676                   1.946                    1.305                  2.664                  0.8499                  3.967        2.857
  Kurtosis                              1.577                   2.856                    0.3212                 9.159                  1.889                   16.94        9.215
  Sum                                   329,491                 53,631                   154,083                110,169                53.1                    270,705      74.97

When the data (population versus pharmacists) are plotted separating into larger (n=8) and smaller (n=17) EU member states with a cut-off after The Netherlands (16.6 M), results are similar with slopes of 758 ± 202 and 728 ± 155 (t-test for difference between slopes: P\>0.05) for larger and smaller countries; medians are 1545 (percentiles 879, 3,282) and 1628 (percentiles 977 and 6,097), respectively.

Thus in the above and almost all of the following cases there are no significant differences in results from larger and smaller EU countries (data not shown).

Community pharmacies, pharmacists and assistants
------------------------------------------------

Reported numbers of community pharmacists expressed as a ratio of the EU linear regression estimation, gives a median value (0.92, percentiles 0.25 and 1.49) not significantly different from 1 (P\>0.05) (tables 6, 7). Belgium (1.64) and Sweden (0.22) are outside the limits. Thus Belgium has more and Sweden less community pharmacists than the EU linear regression estimation.

The median number of pharmacies is 2380. Ratios compared to the EU linear regression estimation ([tables 6](#T6){ref-type="table"}, [7](#T7){ref-type="table"}) showed 4 countries outside the percentile limits (0.32, 1.86): Greece (3.23), Bulgaria (1.99), Denmark (0.19) and Slovenia (0.18). Thus Greece has more than 3-fold, Bulgaria twice, and Denmark and Sweden one-fifth, the number of pharmacies. There are 3585 persons per pharmacy.

###### 

Community pharmacies. pharmacists and assistants: reported data as a ratio of the EU linear regression estimation (NA: data not available).

                           Community pharmacies   Community pharmacists   Assistants
  ------------------------ ---------------------- ----------------------- ------------
  Austria                  0.51                   0.9                     1.35
  Belgium                  1.78                   1.64                    1.3
  Bulgaria                 1.99                   1.16                    NA
  Czech Republic           0.77                   0.84                    0.94
  Denmark                  0.19                   0.25                    1.25
  Estonia                  1.28                   1.32                    1.24
  Finland                  0.5                    0.38                    1.53
  France                   1.2                    1.26                    1.17
  Germany                  0.88                   1.03                    0.32
  Greece                   3.23                   1.48                    0.77
  Hungary                  0.8                    0.72                    1.16
  Ireland                  1.21                   1.11                    0.26
  Italy                    0.98                   0.98                    NA
  Latvia                   1.24                   1.09                    1.45
  Lithuania                1.34                   1.32                    1.23
  Malta                    1.71                   1.03                    0.99
  Netherlands              0.4                    0.28                    2.21
  Poland                   0.94                   0.83                    1.13
  Portugal                 0.84                   0.85                    0.93
  Rumania                  0.9                    0.92                    NA
  Slovakia                 1.15                   0.79                    0.83
  Slovenia                 0.18                   0.25                    0.18
  Spain                    1.5                    1.5                     NA
  Sweden                   0.43                   0.22                    1.58
  United Kingdom           0.74                   0.52                    0.52
  NA: data not available                                                  

###### 

Community pharmacies. pharmacists and assistants: reported data as a ratio of the EU linear regression estimation: statistical analysis.

                                        Community pharmacists   Community pharmacies   Assistants
  ------------------------------------- ----------------------- ---------------------- ------------
  Number of values                      25                      25                     21
  Median                                0.94                    0.92                   1.16
  10% Percentile                        0.316                   0.25                   0.272
  90% Percentile                        1.864                   1.488                  1.57
  Mean                                  1.068                   0.9068                 1.064
  Standard deviation                    0.6544                  0.4121                 0.4826
  Standard error                        0.1309                  0.08242                0.1053
  KS normality test                                                                     
  KS distance                           0.1386                  0.1084                 0.126
  P value                               \>0.10                  \>0.10                 \>0.10
  Passed normality test (alpha=0.05)?   Yes                     Yes                    Yes
  P value summary                       ns                      ns                     ns
  Skewness                              1.495                   -0.2192                0.01617
  Kurtosis                              3.844                   -0.7203                0.614
  Sum                                   26.69                   22.67                  22.34
  ns: not significant                                                                  

There are 2.10 (percentile limits 1.27, 3.02) pharmacists per pharmacy in Europe. Most countries show values grouped within a narrow range from 1.0 (Greece) to 2.4 (France). Three northern/central European countries have larger values: Denmark: 3.0, Slovenia: 3.1, and Austria: 4.1.

There are 4,598 assistants per country (percentiles 481, 30,516). Ratios compared to the EU linear regression estimation ([table 6](#T6){ref-type="table"}, [7](#T7){ref-type="table"}) show 4 countries outside percentile limits: The Netherlands (2.21), Sweden (1.58), Ireland (0.26) and Slovenia (0.18). The median number of assistants per pharmacy is 1.63 (percentiles 0.43, 9.59, [table 5](#T5){ref-type="table"}) with a minimum of 0.3 (Ireland) and a maximum of 10.1 (Denmark) ([table 4](#T4){ref-type="table"}).

The education of assistants is carried out at a university faculty in three cases (Finland, Romania and Sweden); in all other cases education is given in a technical college or high school.

Hospital pharmacies and pharmacists
-----------------------------------

There are 115 hospital pharmacies per country (percentiles: 18, 662, n=23) and 375 hospital pharmacists (97, 4,159, n=24; [table 2](#T2){ref-type="table"}). There are 92,174 persons per hospital pharmacy and 28,669 per hospital pharmacist ([tables 8](#T8){ref-type="table"}, [9](#T9){ref-type="table"}).

###### 

Hospital pharmacies and hospital pharmacists (NA: data not available).

                           Hospital pharmacies   Population / hospital pharmacy   Hospital pharmacists   Population / hospital pharmacist
  ------------------------ --------------------- -------------------------------- ---------------------- ----------------------------------
  Austria                  NA                                                     292                    28,767
  Belgium                  267                   40,449                           500                    21,600
  Bulgaria                 NA                                                     114                    66,667
  Czech Republic           86                    122,093                          220                    47,727
  Denmark                  15                    366,667                          270                    20,370
  Estonia                  23                    56,522                           100                    13,000
  Finland                  224                   24,107                           545                    9908
  France                   2,594                 24,942                           5,574                  11,607
  Germany                  438                   186,758                          1,890                  43,280
  Greece                   115                   98,261                           302                    37,417
  Hungary                  115                   86,957                           350                    28,571
  Ireland                  76                    59,211                           474                    9,494
  Italy                    297                   203,367                          2,745                  22,004
  Latvia                   38                    57,895                           94                     23,404
  Lithuania                54                    61,111                           NA                      
  Malta                    8                     50,000                           120                    3,333
  Netherlands              100                   166,000                          400                    41,500
  Poland                   708                   53,814                           1,100                  34,636
  Portugal                 115                   92,174                           738                    14,363
  Rumania                  594                   36,195                           692                    31,069
  Slovakia                 50                    108,000                          159                    33,962
  Slovenia                 29                    186,207                          78                     69,231
  Spain                    288                   163,889                          1,612                  29,280
  Sweden                   73                    127,397                          200                    46,500
  United Kingdom           505                   122,772                          6,213                  9,979
  NA: data not available                                                                                 

###### 

Hospital pharmacies and hospital pharmacists: statistical analysis

  ------------------------------------------------------------------------------------------------------------------------------------------------------
                                        Hospital pharmacies   Population / hospital pharmacy   Hospital pharmacists   Population / hospital pharmacist
  ------------------------------------- --------------------- -------------------------------- ---------------------- ----------------------------------
  Number of values                      23                    23                               24                     24

  Median                                115                   92,174                           375                    28,669

  10% Percentile                        18                    29,443                           97                     9,701

  90% Percentile                        662                   196,723                          4,159                  57,197

  Mean                                  296                   108,469                          1,033                  29,070

  Standard deviation                    539                   78,648                           1,635                  17,363

  Standard error                        112                   16,399                           334                    3,544

  KS normality test                                                                                                    

  KS distance                           0.3                   0.2                              0.3                    0.09

  P value                               \<0,0001              \>0,10                           \<0,0001               \>0,10

  Passed normality test (alpha=0.05)?   No                    Yes                              No                     Yes

  P value summary                       \*\*\*                ns                               \*\*\*                 ns

  Skewness                              4                     2                                2                      0.7

  Kurtosis                              16                    4                                6                      0.3

  Sum                                   6,812                 2,000,000                        24,782                 697,669

  ns: not significant.\                                                                                               
  \*\*\*: P\<0.001                                                                                                    
  ------------------------------------------------------------------------------------------------------------------------------------------------------

Ratios compared to the EU linear regression estimation show 4 countries outside percentiles limits (0.36, 2.50) for hospital pharmacies: Denmark (0.19), Italy (0.35), Finland (2.96) and France (2.86), and 4 for hospital pharmacists: Slovenia (0.28), Bulgaria (0.29), Ireland (2.03) and Malta (5.77), ([tables 10](#T10){ref-type="table"}, [11](#T11){ref-type="table"}).

###### 

Hospital pharmacies and hospital pharmacists: actual data as a ratio of the EU linear regression estimation (NA: data not available).

                           Hospital pharmacies   Hospital pharmacists
  ------------------------ --------------------- ----------------------
  Austria                  NA                    0.67
  Belgium                  1.77                  0.89
  Bulgaria                 NA                    0.29
  Czech Republic           0.59                  0.4
  Denmark                  0.19                  0.94
  Estonia                  1.26                  1.48
  Finland                  2.96                  1.94
  France                   2.86                  1.66
  Germany                  0.38                  0.44
  Greece                   0.73                  0.51
  Hungary                  0.82                  0.67
  Ireland                  1.21                  2.03
  Italy                    0.35                  0.87
  Latvia                   1.23                  0.82
  Lithuania                1.17                  NA
  Malta                    1.43                  5.77
  Netherlands              0.43                  0.46
  Poland                   1.33                  0.56
  Portugal                 0.77                  1.34
  Rumania                  1.97                  0.62
  Slovakia                 0.66                  0.57
  Slovenia                 0.38                  0.28
  Spain                    0.44                  0.66
  Sweden                   0.56                  0.41
  United Kingdom           0.58                  1.93
  NA: data not available                         

###### 

Hospital pharmacies and hospital pharmacists: actual data as a ratio of the EU linear regression estimation: statistical analysis

  ----------------------------------------------------------------------------------
                                        Hospital pharmacies   Hospital pharmacists
  ------------------------------------- --------------------- ----------------------
  Number of values                      23                    24

  Median                                0.77                  0.67

  10% Percentile                        0.362                 0.345

  90% Percentile                        2.504                 1.985

  Mean                                  1.047                 1.092

  Standard deviation                    0.7559                1.135

  Standard error                        0.1576                0.2317

  Lower 95% CI of mean                  0.7196                0.6128

  Upper 95% CI of mean                  1.373                 1.571

  KS normality test                                            

  KS distance                           0.183                 0.2616

  P value                               0.0443                0.0002

  Passed normality test (alpha=0.05)?   No                    No

  P value summary                       \*                    \*\*\*

  Skewness                              1.359                 3.293

  Kurtosis                              1.463                 12.98

  Sum                                   24.07                 26.21

  \*: P\<0.05\                                                
  \*\*\*: P\<0.001                                            
  ----------------------------------------------------------------------------------

Industrial pharmacists
----------------------

The median number of industrial pharmacists is 737 (percentiles 35, 5,276) with 13,831 (percentiles of 7,188 and 53,338) persons per industrial pharmacist ([table 2](#T2){ref-type="table"}).

Other activities and occupations
--------------------------------

The median number of pharmacists in other occupations is 400 (percentiles 75, 6,877) ([table 2](#T2){ref-type="table"}).

Higher education institutions (HEIs)
------------------------------------

There are 195 public HEIs in the EU with 144 (74%) in the 8 larger countries ([tables 12](#T12){ref-type="table"}, [13](#T13){ref-type="table"}). There are 12 private HEIs: 1 each in Ireland and Romania, 4 in Portugal and 6 in Spain. Ratios compared to the EU linear regression estimation show 3 countries outside percentile limits (0.55, 2.36): Czech Republic (0.51), The Netherlands (0.33) and Malta (6.76) ([tables 14](#T14){ref-type="table"}, [15](#T15){ref-type="table"}). It should be noted that the actual numbers of HEIs in these 3 countries are low.

###### 

Higher education institutions, staff and students: data (NA: data not available).

                           Number HEIs   Staff   Staff / HEI   Students   Students / staff   Students / pharmacist
  ------------------------ ------------- ------- ------------- ---------- ------------------ -----------------------
  Austria                  3             58      19            NA                             
  Belgium                  9             185     21            1000       27                 0.075
  Bulgaria                 3             200     67            334        8                  0.047
  Czech Republic           2             190     95            430        11                 0.068
  Denmark                  2             90      45            230        13                 0.063
  Estonia                  1             14      14            48         17                 0.031
  Finland                  3             300     100           475        8                  0.155
  France                   24            NA                    3,337                         0.044
  Germany                  22            NA                    NA                             
  Greece                   3             90      30            400        22                 0.031
  Hungary                  4             NA                    NA                             
  Ireland                  3             91      30            150        8                  0.037
  Italy                    32                                  NA                             
  Latvia                   2             115     58            86         4                  0.043
  Lithuania                1             185     185           96         3                  0.030
  Malta                    1             10      10            48         24                 0.077
  Netherlands              2             NA                    NA                             
  Poland                   10            1,446   145           1658       6                  0.073
  Portugal                 9             952     106           1021       5                  0.094
  Rumania                  10            1000    100           2500       13                 0.174
  Slovakia                 2             NA                    NA                             
  Slovenia                 1             65      65            181        14                 0.112
  Spain                    19            1865    98            3168       8                  0.051
  Sweden                   2             170     85            270        8                  0.084
  United Kingdom           25            902     36            3500       19                 0.111
  NA: data not available                                                                     

###### 

Higher education institutions, staff and students: statistical analysis.

  -----------------------------------------------------------------------------------------------------------------------------------
                                        Number HEIs   Staff       Staff / HEI   Students   Students / staff   Students / pharmacist
  ------------------------------------- ------------- ----------- ------------- ---------- ------------------ -----------------------
  Number of values                      25            20          20            19         19                 19

  Median                                3.0           185         61.5          400        8                  0.06849

  10% Percentile                        1.0           18.4        14.5          48         3                  0.03068

  90% Percentile                        24.4          1437        141.1         3337       24                 0.1547

  Mean                                  7.8           464.1       67.55         996.4      11.47              0.07376

  Standard deviation                    9.129         567.7       46.53         1213       7.449              0.04088

  Standard error                        1.826         126.9       10.41         278.3      1.709              0.009379

  KS normality test                                                                                            

  KS distance                           0.3014        0.3291      0.136         0.2979     0.2058             0.1534

  P value                               \< 0.0001     \< 0.0001   \> 0.10       0.0001     0.0333             \> 0.10

  Passed normality test (alpha=0.05)?   No            No          Yes           No         No                 Yes

  P value summary                       \*\*\*        \*\*\*      ns            \*\*\*     \*                 ns

  Skewness                              1.475         1.319       0.8929        1.268      0.6478             1.156

  Kurtosis                              1.009         0.5114      0.5792        0.07911    -0.3417            0.9153

  Sum                                   195           9282        1351          18931      218                1.401

  ns: not significant\                                                                                        
  \*: P\<0.05\                                                                                                
  \*\*\*: P\<0.001                                                                                            
  -----------------------------------------------------------------------------------------------------------------------------------

###### 

Higher education institutions. staff and students: actual data as a ratio of the EU linear regression estimation.

                           Number HEIs   Staff   Students
  ------------------------ ------------- ------- ----------
  Austria                  0.97          0.26    NA
  Belgium                  2.25          0.66    1.61
  Bulgaria                 1.07          1.01    0.76
  Czech Republic           0.51          0.69    0.71
  Denmark                  0.98          0.63    0.73
  Estonia                  2.08          0.41    0.64
  Finland                  1.5           2.13    1.53
  France                   1,00          NA      0.9
  Germany                  0.73          NA      NA
  Greece                   0.72          0.3     0.62
  Hungary                  1.08          NA      NA
  Ireland                  1.8           0.77    0.58
  Italy                    1.43          0.86    NA
  Latvia                   2.46          2,00    0.68
  Lithuania                0.82          2.14    0.51
  Malta                    6.76          0.96    2.09
  Netherlands              0.33          NA      NA
  Poland                   0.71          1.45    0.76
  Portugal                 2.29          3.44    1.68
  Rumania                  1.26          1.78    2.02
  Slovakia                 1,00          NA      NA
  Slovenia                 1.35          1.24    1.57
  Spain                    1.09          1.51    1.17
  Sweden                   0.58          0.7     0.51
  United Kingdom           1.09          0.56    0.98
  NA: data not available                         

###### 

Higher education institutions. staff and students: actual data as a ratio of the EU linear regression estimation: statistical analysis.

  -----------------------------------------------------------------------
                                        Number HEIs   Staff    Students
  ------------------------------------- ------------- -------- ----------
  Number of values                      25            20       19

  Median                                1.08          0.91     0.76

  10% Percentile                        0.552         0.311    0.51

  90% Percentile                        2.358         2.139    2.02

  Mean                                  1.434         1.175    1.055

  Standard deviation                    1.249         0.7993   0.5247

  Standard error                        0.2497        0.1787   0.1204

  KS normality test                                             

  KS distance                           0.239         0.1818   0.2395

  P value                               0.0007        0.0822   0.0054

  Passed normality test (alpha=0.05)?   No            Yes      No

  P value summary                       \*\*\*        ns       \*\*

  Skewness                              3.467         1.315    0.8148

  Kurtosis                              14.44         1.897    -0.7723

  Sum                                   35.86         23.5     20.05

  ns: not significant\                                         
  \*\*: P\<0.01\                                               
  \*\*\*: P\<0.001                                             
  -----------------------------------------------------------------------

In 12 countries (Czech Republic, Denmark, Finland, France, Hungary, Italy, Latvia, Poland, Slovakia, Slovenia, Spain and Sweden) HEIs are independent faculties. In 5 countries (Austria, Germany, The Netherlands, Portugal and United Kingdom) HEIs are part of a science department. In 7 countries (Belgium, Bulgaria, Estonia, Ireland, Lithuania, Malta and Romania) HEIs are part of a medical department. In Greece Athens has an independent faculty, Thessaloniki and Patras have faculties within the school of Health Sciences.

Staff
-----

An EU country has 185 staff teaching pharmacy (percentiles: 18.4, 1,437) with 62 staff per HEI (percentiles: 14.5, 141) ([table 13](#T13){ref-type="table"}). Ratios compared to the EU linear regression estimation show 2 countries outside percentile limits (0.31, 2.10): Austria (0.26) and Portugal (3.44) ([table 14](#T14){ref-type="table"}).

Students
--------

An EU country has 400 pharmacy students (percentiles: 48, 3,337) with 8 students per staff member (percentiles: 3.0, 24) ([table 13](#T13){ref-type="table"}). Ratios compared to the EU linear regression estimation show no countries outside percentile limits ([tables 14](#T14){ref-type="table"}, [15](#T15){ref-type="table"}). There are 0.068 students per working pharmacist (percentiles: 0.031, 0.174) ([table 13](#T13){ref-type="table"}).

Courses
-------

In opposition to the data above, data relating to percentage of the 7 subject areas in the course were almost all of normal distribution ([tables 16](#T16){ref-type="table"}, [17](#T17){ref-type="table"}). Medical sciences (MEDSCI) represent the main subject area (28%) followed by chemical sciences (CHEMSCI: 24%), pharmaceutical technology (PHARMTECH: 15%), biological sciences (BIOLSCI: 11%), physics/mathematics (PHYSMATH: 6.4%), generic subjects (GENERIC: 6.4%) and law/society/ethics (LAWSOC: 6.2%).

###### 

Subject areas in %: reported data.

  ----------------------------------------------------------------------------------------------------------------
                                           CHEMSCI   PHYSMATH   BIOLSCI   PHARMTECH   MEDISCI   LAWSOC   GENERIC
  ---------------------------------------- --------- ---------- --------- ----------- --------- -------- ---------
  Austria                                  44.0      2.0        22.0      14.0        16.0      0.60     1.00

  Belgium                                  24.0      9.0        11.0      18.0        27.0      2.00     8.00

  Bulgaria                                 31.0      7.0        11.0      13.0        24.0      7.00     7.00

  Czech Republic                           17.0      5.0        8.0       22.0        19.0      13.00    16.00

  Denmark                                  42.0      7.0        7.0       16.0        16.0      9.00     3.00

  Estonia                                  21.0      4.0        2.0       21.0        39.0      10.00    3.00

  Finland                                  20.0      5.6        2.5       21.9        28.8      15.60    5.60

  France                                   17.6      9.5        17.9      5.9         42.0      2.20     5.00

  Germany                                  39.8      4.5        10.9      13.4        28.3      2.10     3.80

  Greece                                   39.3      5.8        14.2      8.2         15.9      2.70     14.00

  Hungary                                  27.2      5.2        5.2       16.0        28.5      3.88     14.22

  Ireland                                  13.6      11.1       7.1       18.3        35.5      7.30     7.10

  Italy                                    32.4      7.2        10.4      9.1         31.5      4.80     2.20

  Latvia                                   27.7      6.4        6.4       20.2        26.6      8.50     6.40

  Lithuania                                28.0      2.6        11.7      11.7        36.4      9.80     9.80

  Malta                                    15.4      7.2        12.7      15.4        30.8      3.60     15.00

  Netherlands                              20.1      3.9        10.6      14.2        31.1      8.30     11.80

  Poland                                   21.3      4.1        8.0       15.9        38.2      6.20     6.20

  Portugal                                 19.6      6.8        14.6      14.9        32.2      12.00    1.20

  Rumania                                  26.1      8.7        15.8      14.1        24.9      3.70     6.60

  Slovakia                                 28.8      8.8        10.9      14.4        27.6      3.40     6.00

  Slovenia                                 27.0      8.5        8.5       22.0        21.0      8.50     4.70

  Spain                                    23.5      5.5        19.9      11.0        27.6      5.50     7.00

  Sweden                                   18.3      11.3       12.8      19.5        21.5      11.80    5.00

  United Kingdom                           13.6      5.7        23.9      22.7        23.9      3.40     6.80

  CHEMSCI: chemical sciences\                                                                            
  PHYSMATH: physics, mathematics\                                                                        
  BIOLSCI: biological sciences\                                                                          
  PHARMTECH: pharmaceutical technology\                                                                  
  MEDISCI: medical sciences\                                                                             
  LAWSOC: law, society, ethics\                                                                          
  GENERIC: generic subjects, traineeship                                                                 
  ----------------------------------------------------------------------------------------------------------------

###### 

Subject areas in %: statistical analysis.

  -------------------------------------------------------------------------------------------------------------
                                        CHEMSCI   PHYSMATH   BIOLSCI   PHARMTECH   MEDISCI   LAWSOC   GENERIC
  ------------------------------------- --------- ---------- --------- ----------- --------- -------- ---------
  Number of values                      25        25         25        25          25        25       25

  Median                                24        6.4        11        15          28        6.2      6.4

  10% Percentile                        15        3.4        4.1       8.7         16        2.1      1.8

  90% Percentile                        41        10         21        22          39        12       15

  Mean                                  26        6.5        11        16          28        6.6      7.1

  Standard deviation                    8.7       2.4        5.5       4.6         7.2       4        4.2

  Standard error                        1.7       0.48       1.1       0.91        1.4       0.79     0.85

  KS normality test                                                                                    

  KS distance                           0.13      0.11       0.13      0.11        0.081     0.15     0.22

  P value                               \>0.10    \>0.10     \>0.10    \>0.10      \>0.10    \>0.10   0.004

  Passed normality test (alpha=0.05)?   Yes       Yes        Yes       Yes         Yes       Yes      No

  P value summary                       ns        ns         ns        ns          ns        ns       \*\*

  Skewness                              0.7       0.23       0.55      -0.23       0.071     0.51     0.78

  Kurtosis                              -0.29     -0.35      0.19      -0.48       -0.5      -0.54    -0.13

  Sum                                   638       162        285       393         693       165      176

  ns: not significant\                                                                                
  \*\*: P\<0.01                                                                                       
  -------------------------------------------------------------------------------------------------------------

When subject area percentages were tested for correlations amongst them, the only significant correlation (negative) emerging was that between medical and chemical sciences ([figure 1](#F1){ref-type="fig"}). Some countries had a more "medical" course: MEDSCI % / CHEMSCI % = 2.38 for France, 1.85 for Estonia and 1.79 for Poland. Others had more "chemical" courses: MEDSCI % / CHEMSCI % = 0.71 for Germany, 0.40 for Greece, 0.38 for Denmark, 0.36 for Austria.

![Relationship between MEDSCI and CHEMSCI. (CHEMSCI: chemical sciences; MEDISCI: medical sciences)](pharmpract-09-169-g1){#F1}

Traineeship
-----------

Traineeship was mainly in community pharmacy (58%) with 26% in hospital and 16% in industrial settings (details see [tables 18](#T18){ref-type="table"}, [19](#T19){ref-type="table"}, [20](#T20){ref-type="table"}, [21](#T21){ref-type="table"}, [22](#T22){ref-type="table"}, [23](#T23){ref-type="table"} and [figure 2](#F2){ref-type="fig"}). Traineeship was mainly in the fifth year (74%) but some countries such as Finland, France, Germany, Hungary and Malta started significant traineeship early - in the first or second year.

###### 

Traineeship -- community (hours): reported data.

                   Year 1   Year 2   Year 3   Year 4   Year 5
  ---------------- -------- -------- -------- -------- --------
  Austria          0        0        0        0        0
  Belgium          0        0        0        0        1000
  Bulgaria         0        0        0        0        800
  Czech Republic   40       0        0        0        960
  Denmark          0        0        0        1040     0
  Estonia          0        0        0        0        410
  Finland          0        520      520      0        0
  France           0        320      80       80       0
  Germany          160      160      0        0        800
  Greece           0        0        0        0        960
  Hungary          0        140      140      140      560
  Ireland          0        0        0        0        960
  Italy            0        0        0        250      500
  Latvia           0        0        0        0        648
  Lithuania        0        0        0        0        935
  Malta            84       84       84       42       1000
  Netherlands      0        0        0        160      0
  Poland           0        0        160      0        0
  Portugal         0        0        0        39       640
  Rumania          60       60       60       60       780
  Spain            0        0        0        0        450
  Slovakia         0        0        0        160      800
  Slovenia         0        0        0        0        720
  Sweden           0        0        0        0        1040
  United Kingdom   12       80       0        0        0

###### 

Traineeship -- community (hours): statistical analysis.

  -------------------------------------------------------------------------------------------
                                        Year 1     Year 2     Year 3     Year 4     Year 5
  ------------------------------------- ---------- ---------- ---------- ---------- ---------
  Number of values                      25         25         25         25         25

  Median                                0          0          0          0          648

  10% Percentile                        0          0          0          0          0

  90% Percentile                        69.6       224        148        196        1000

  Mean                                  14.24      56.48      41.76      78.84      558.5

  Standard deviation                    37.04      122.1      109.7      211.4      394.4

  Standard error                        7.408      24.41      21.95      42.28      78.87

  KS normality test                                                                  

  KS distance                           0.4497     0.3582     0.4082     0.3546     0.2016

  P value                               \<0.0001   \<0.0001   \<0.0001   \<0.0001   0.0101

  Passed normality test (alpha=0.05)?   No         No         No         No         No

  P value summary                       \*\*\*     \*\*\*     \*\*\*     \*\*\*     \*

  Skewness                              3.111      2.902      3.794      4.247      -0.4686

  Kurtosis                              10.25      8.957      16.02      19.49      -1.373

  Sum                                   356        1,412      1,044      1,971      13,963

  \*: P\<0.05\                                                                      
  \*\*\*: P\<0.001                                                                  
  -------------------------------------------------------------------------------------------

###### 

Traineeship -- hospital (hours): reported data.

                   Year 1   Year 2   Year 3   Year 4   Year 5
  ---------------- -------- -------- -------- -------- --------
  Austria          0        0        0        0        0
  Belgium          0        0        0        0        0
  Bulgaria         0        0        0        0        800
  Czech Republic   0        80       0        0        0
  Denmark          0        0        0        0        0
  Estonia          0        0        0        0        90
  Finland          0        0        0        0        0
  France           0        0        0        0        960
  Germany          160      160      0        0        800
  Greece           0        0        0        0        960
  Hungary          0        0        140      140      140
  Ireland          0        0        0        0        960
  Italy            0        0        0        250      500
  Latvia           0        0        0        0        648
  Lithuania        0        0        0        0        40
  Malta            0        0        80       500      0
  Netherlands      0        0        0        0        0
  Poland           0        0        0        160      0
  Portugal         0        0        0        0        320
  Rumania          0        0        0        0        0
  Spain            0        0        0        0        450
  Slovakia         0        0        0        0        0
  Slovenia         0        0        0        0        0
  Sweden           0        0        0        0        0
  United Kingdom   6        12       12       0        0

###### 

Traineeship -- hospital (hours): statistical analysis.

                                        Year 1     Year 2     Year 3     Year 4     Year 5
  ------------------------------------- ---------- ---------- ---------- ---------- ----------
  Number of values                      25         25         25         25         25
  Median                                0          0          0          0          0
  10% Percentile                        0          0          0          0          0
  90% Percentile                        2.4        39.2       39.2       196        960
  Mean                                  6.64       10.08      9.28       42         266.7
  Standard deviation                    31.97      35.12      31.62      114.3      369.1
  Standard error                        6.394      7.024      6.323      22.86      73.83
  KS normality test                                                                  
  KS distance                           0.5023     0.4929     0.4954     0.4833     0.2904
  P value                               \<0.0001   \<0.0001   \<0.0001   \<0.0001   \<0.0001
  Passed normality test (alpha=0.05)?   No         No         No         No         No
  P value summary                       \*\*\*     \*\*\*     \*\*\*     \*\*\*     \*\*\*
  Skewness                              4.989      3.856      3.683      3.217      1.001
  Kurtosis                              24.92      15.2       13.57      11.08      -0.6776
  Sum                                   166        252        232        1,050      6,668
  \*\*\*: P\<0.001                                                                  

###### 

Traineeship -- industry (hours): reported data.

                   Year 1   Year 2   Year 3   Year 4   Year 5
  ---------------- -------- -------- -------- -------- --------
  Austria          0        0        0        0        0
  Belgium          0        0        0        0        1,000
  Bulgaria         0        0        0        0        0
  Czech Republic   0        0        0        0        0
  Denmark          0        0        0        0        0
  Estonia          0        0        0        0        0
  Finland          0        0        0        0        0
  France           0        0        320      0        0
  Germany          160      160      0        0        800
  Greece           0        0        0        0        0
  Hungary          0        0        140      140      0
  Ireland          0        0        0        0        960
  Italy            0        0        0        250      500
  Latvia           0        0        0        0        0
  Lithuania        0        0        0        0        0
  Malta            0        0        80       500      0
  Netherlands      0        0        0        0        0
  Poland           0        0        0        0        0
  Portugal         0        0        0        0        0
  Rumania          0        0        0        0        0
  Spain            0        0        100      100      100
  Slovakia         0        0        0        0        0
  Slovenia         0        0        0        0        0
  Sweden           0        0        0        0        0
  United Kingdom   0        0        0        0        0

###### 

Traineeship -- industry (hours): statistical analysis.

                                        Year 1     Year 2     Year 3     Year 4     Year 5
  ------------------------------------- ---------- ---------- ---------- ---------- ----------
  Number of values                      25         25         25         25         25
  Median                                0          0          0          0          0
  10% Percentile                        0          0          0          0          0
  90% Percentile                        0          0          116        184        864
  Mean                                  6.4        6.4        25.6       39.6       134.4
  Standard deviation                    32         32         71.3       112.3      314.2
  Standard error                        6.4        6.4        14.26      22.47      62.85
  KS normality test                                                                  
  KS distance                           0.5393     0.5393     0.4802     0.4778     0.4656
  P value                               \<0.0001   \<0.0001   \<0.0001   \<0.0001   \<0.0001
  Passed normality test (alpha=0.05)?   No         No         No         No         No
  P value summary                       \*\*\*     \*\*\*     \*\*\*     \*\*\*     \*\*\*
  Skewness                              5          5          3.403      3.413      2.199
  Kurtosis                              25         25         12.6       12.4       3.428
  Sum                                   160        160        640        990        3360
  \*\*\*: P\<0.001                                                                  

![Traineeship : hours per year for individual countries (each bar represents a country).](pharmpract-09-169-g2){#F2}

Analysis revealed medians that were often equal to zero given the large number of zeros in a given category.

Discussion
==========

A total of 419,353 pharmacists work in the 25 EU countries surveyed. This gives a mean value of 16,774 pharmacists per country with a median of 6,278. The mean and median are very different as the distribution of the data is highly skewed. This is due to the fact that the population of the EU (n=25) - 501 million - is roughly distributed into larger and smaller countries. Twenty % of the population of the EU lives in 17 smaller countries: Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, Finland, Greece, Hungary, Ireland, Latvia, Lithuania, Malta, Portugal, Slovakia, Slovenia and Sweden, and 80% lives in 8 larger countries: France, Germany, Italy, The Netherlands, Poland, Romania, Spain and United Kingdom. As a consequence of this, many of the analyses are presented using medians. Furthermore, data were also analysed by separating countries into two groups -- larger and smaller countries -- but no significant differences were observed between the two groups.

Community pharmacies and community, hospital and industrial pharmacists are unevenly distributed in the EU ([table 24](#T24){ref-type="table"}), some countries having ratios of reported number / EU linear regression estimation of \>0.5 (i.e. less than half the number to be expected from the population of the country), and some with ratios of \>1.5 (i.e. 1.5x or more the number expected).

###### 

Countries with extremes of ratios of reported data / EU linear regression estimation.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Ratios of reported data / EU linear regression estimation   Community pharmacies          Community pharmacists         Hopital pharmacists                    Industrial pharmacists
  ----------------------------------------------------------- ----------------------------- ----------------------------- -------------------------------------- ---------------------------------------------------
  0.5 and lower                                               Sweden, Slovenia, Denmark,\   Sweden, Slovenia, Denmark,\   Slovenia, Bulgaria, Czech Republic,\   Czech Republic, Romania,\
                                                              The Netherlands, Finland      The Netherlands, Finland      Sweden, Germany, The Netherlands       Greece, Estonia, UK, Ireland, Lithuania, Slovakia

  1.5 and greater                                             Spain, Belgium                Spain, Malta, Belgium,\       France, UK, Finland,\                  Hungary, Sweden, Bulgaria,\
                                                                                            Bulgaria, Greece              Ireland, Malta                         Latvia, Finland, Malta, Spain, Denmark
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Most (70%) of pharmacists work as community pharmacists with the tasks reported in [table 3](#T3){ref-type="table"}. In order to evaluate whether pharmacy education and training is adapted to needs, correlations were calculated between the numbers of community pharmacists and the number of HEIs and pharmacy students. These were highly significant in both cases: r^2^=0.77 (P\<0.0001) and 0.75 (P\<0.0001), respectively. Thus in terms of numbers of future pharmacists, EU HEIs appear to be connected to the needs.

Pharmacists working in hospitals and industry have clearly identified roles and competences ([table 3](#T3){ref-type="table"}). In order to evaluate whether pharmacy education and training is adapted to such needs, correlations were calculated between the ratios of hospital and industrial pharmacists (reported number / EU linear regression estimation) and the ratio CHEMSCI+PHARMTECH / MEDSCI. It was argued that countries with higher numbers of hospital pharmacists would have courses more oriented towards medical sciences: MEDSCI (human anatomy and physiology, medical terminology, pharmacology, pharmacognosy, pharmacotherapy / therapeutics, toxicology, pathology, histology, microbiology, nutrition, non-pharmacological treatment, haematology, immunology, parasitology, hygiene, emergency therapy, clinical chemistry / bio-analysis (of body fluids), radiochemistry, dispensing process, drug prescription, prescription analysis (detection of adverse effects and drug interactions), generic drugs, planning, running and interpretation of the data of clinical trials, medical devices, orthopaedics, OTC medicines, complementary therapy, at-home support and care, skin illness and treatment, homeopathy, phytotherapy, drugs in veterinary medicine, pharmaceutical care, pharmaceutical therapy of illness and disease). Likewise those with higher numbers of industrial pharmacists would have courses more oriented toward chemical sciences: CHEMSCI (general, organic & inorganic chemistry, analytical chemistry, pharmaceutical chemistry / pharmacopeia analysis, medicinal physic-chemistry / SAR / drug design) and pharmaceutical technology: PHARMTECH (galenic formulation / pharmaceutics, drug disposition and metabolism (ADME) / pharmacokinetics, novel drug delivery systems, drug design, pharmaceutical R&D, drug production, quality assurance in production, drug / new chemical entity registration and regulation, common technical document (quality (pharmaceutical), safety (safety pharmacology and toxicology), efficacy (preclinical and clinical studies)), ophthalmic preparations, medical gases, cosmetics, management strategy in industry, economics of the pharmaceutical industry and R&D). In neither case were correlations significant: hospital pharmacists r^2^=0.15, P=0.069, industrial pharmacists r^2^=0.12, P=0.115. At the extremes, however, courses were oriented. Thus Ireland with a ratio for hospital pharmacists of 2.03 (twice as many hospital pharmacists as to be expected from the EU linear regression estimation) had a CHEMSCI+PHARMTECH / MEDSCI ratio of 0.38. Denmark with a ratio for industrial pharmacists of 4.47 (4.5 times as many industrial pharmacists as to be expected from the EU linear regression estimation) had a CHEMSCI+PHARMTECH / MEDSCI ratio of 3.63.

A couple of provisos have to be added, however. Firstly, whilst community pharmacists are registered by their national chamber and thus their numbers are accurately known, this is often not the case for hospital or industrial pharmacists and thus their numbers may be less accurate. Secondly, whilst the content of the degree course for community pharmacists is fixed by the annex of the EU directive 2005/36 (see above), this is not the case for hospital and industrial pharmacists. A large variety in the course proposed is observed. In France future hospital pharmacists have extensive pre-graduate training in hospital pharmacy and also undergo a 4-year hospital internship. In other countries there is little specific pre- or post-graduate training for either hospital or industrial pharmacists. The latter are simply defined by their place of work and their roles and responsibilities ([table 3](#T3){ref-type="table"}).

The PHARMINE survey revealed that there is a median of 4598 assistants per country and 1.63 assistants / community pharmacist. Three countries were unable to reply to questions on assistants as the status of such persons is not clearly established in these countries. In most EU countries the main task of assistants is to take care of medicine storage, logistics, invoicing and management of pharmacy IT systems and other such tasks. Their training, which is performed at a high school or college, includes basic modules in chemistry and in physics, healthcare, hygiene, management, economics, bookkeeping, etc.

The education of assistants is carried out at university in three cases (Finland, Romania and Sweden). Taking the case of Finland (<http://www.pharmine.org/losse_paginas/Country_Profiles/Finland/>) following the Bologna declaration (http://enzu.pharmine.org/media/filebook/files/Bologna%20declaration.pdf), pharmacy education is divided into two parts. All the students follow the same curriculum the first three years and graduate with a bachelor degree. Approximately one third of the students continue additional two years to graduate with the master degree, devoted mainly to chemical and medical sciences, generic subjects and pharmaceutical technology, and medical sciences. Those graduating with a bachelor degree have tasks similar to those of pharmacists, but these do not include pharmacy ownership, management or in-depth scientific issues. The main focus is in customer service and patient counselling. In summary, in Finland, both B.Sc. and M.Sc. graduates are involved in dispensation and counselling. Ownership of a pharmacy and/or a position of responsible pharmacist are restricted to M.Sc. graduates.

Traineeship is mainly in a community / hospital setting (84%) and mainly in the fifth and final year, although several countries introduce traineeship earlier -- some in the first year of the degree. In most countries the length of the course is 5 years. There is thus integration of traineeship into the degree course. In some countries (Austria, UK) the course is shorter. Following graduation pharmacists undergo a pre-registration training period that is validated by the national chamber or agency.

In conclusion, the PHARMINE survey of pharmacy and pharmacy education in Europe produced country profiles with extensive information for each country in the EU and several other European countries. These data are available at: <http://www.pharmine.org/losse_paginas/Country_Profiles/>. This 2011 PHARMINE report represents a presentation of the project and the data and some preliminary analysis on the basic question of how pharmacy education is adapted to pharmacy practice in the EU.

This is the 2011 report for the EU. Further reports will be edited in the future as the data is completed, data from other European countries are obtained, situations in individual countries change, etc. Further reports will also deal with other subjects such as the impact of the Bologna declaration and of the EC directives on organisation of university studies, and quality assurance in European pharmacy education.
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